BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20856174)

  • 21. Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes.
    Du S; Zhang X; Jia Y; Peng P; Kong Q; Jiang S; Li Y; Li C; Ding Z; Liu L
    Theranostics; 2023; 13(11):3856-3871. PubMed ID: 37441587
    [No Abstract]   [Full Text] [Related]  

  • 22. TLR4 activation mediates kidney ischemia/reperfusion injury.
    Wu H; Chen G; Wyburn KR; Yin J; Bertolino P; Eris JM; Alexander SI; Sharland AF; Chadban SJ
    J Clin Invest; 2007 Oct; 117(10):2847-59. PubMed ID: 17853945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemoperfusion with a high-mobility group box 1 adsorption column can prevent the occurrence of hepatic ischemia-reperfusion injury in rats.
    Yamamoto T; Ono T; Ito T; Yamanoi A; Maruyama I; Tanaka T
    Crit Care Med; 2010 Mar; 38(3):879-85. PubMed ID: 20029346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.
    Yokota S; Yoshida O; Dou L; Spadaro AV; Isse K; Ross MA; Stolz DB; Kimura S; Du Q; Demetris AJ; Thomson AW; Geller DA
    J Immunol; 2015 Jun; 194(12):6045-56. PubMed ID: 25964490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion.
    Zhai Y; Qiao B; Gao F; Shen X; Vardanian A; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2008 Jan; 47(1):199-206. PubMed ID: 17935177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion.
    van Golen RF; Reiniers MJ; Marsman G; Alles LK; van Rooyen DM; Petri B; Van der Mark VA; van Beek AA; Meijer B; Maas MA; Zeerleder S; Verheij J; Farrell GC; Luken BM; Teoh NC; van Gulik TM; Murphy MP; Heger M
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1192-1200. PubMed ID: 30658161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA MALAT1 cessation antagonizes hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and inflammation via the HMGB1-TLR4 axis.
    Zhang Y; Zhang H; Zhang Z; Li S; Jiang W; Li X; Lv J
    Mol Immunol; 2019 Aug; 112():22-29. PubMed ID: 31075559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice.
    Jin X; Wang L; Wu HS; Zhang L; Wang CY; Tian Y; Zhang JH
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):284-9. PubMed ID: 17548252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.
    Shen XD; Ke B; Zhai Y; Gao F; Tsuchihashi S; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
    Liver Transpl; 2007 Oct; 13(10):1435-43. PubMed ID: 17902130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation.
    Ilmakunnas M; Tukiainen EM; Rouhiainen A; Rauvala H; Arola J; Nordin A; Mäkisalo H; Höckerstedt K; Isoniemi H
    Liver Transpl; 2008 Oct; 14(10):1517-25. PubMed ID: 18825712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon regulatory factor 1-Rab27a regulated extracellular vesicles promote liver ischemia/reperfusion injury.
    Yang MQ; Du Q; Goswami J; Varley PR; Chen B; Wang RH; Morelli AE; Stolz DB; Billiar TR; Li J; Geller DA
    Hepatology; 2018 Mar; 67(3):1056-1070. PubMed ID: 29059701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice.
    Nace GW; Huang H; Klune JR; Eid RE; Rosborough BR; Korff S; Li S; Shapiro RA; Stolz DB; Sodhi CP; Hackam DJ; Geller DA; Billiar TR; Tsung A
    Hepatology; 2013 Jul; 58(1):374-87. PubMed ID: 23460269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between activation of TLR4 and partial hepatic ischemia/reperfusion injury in mice.
    Wang L; Xu JB; Wu HS; Zhang JX; Zhang JH; Tian Y; Wang CY
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):101-4. PubMed ID: 16481293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of HMGB-1 on the development of necrosis during hepatic ischemia and hepatic ischemia/reperfusion injury in mice.
    Watanabe T; Kubota S; Nagaya M; Ozaki S; Nagafuchi H; Akashi K; Taira Y; Tsukikawa S; Oowada S; Nakano S
    J Surg Res; 2005 Mar; 124(1):59-66. PubMed ID: 15734480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate.
    Chung KY; Park JJ; Kim YS
    Transplant Proc; 2008 Sep; 40(7):2136-8. PubMed ID: 18790172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.
    Tsung A; Klune JR; Zhang X; Jeyabalan G; Cao Z; Peng X; Stolz DB; Geller DA; Rosengart MR; Billiar TR
    J Exp Med; 2007 Nov; 204(12):2913-23. PubMed ID: 17984303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury.
    Okaya T; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G606-12. PubMed ID: 14615282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-γ/IRF-1 pathway.
    Klune JR; Bartels C; Luo J; Yokota S; Du Q; Geller DA
    Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G991-G1002. PubMed ID: 30307739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.
    Kim JH; Kim SJ; Lee IS; Lee MS; Uematsu S; Akira S; Oh KI
    J Immunol; 2009 Feb; 182(4):2458-66. PubMed ID: 19201901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury.
    Xu W; Lu Y; Yao J; Li Z; Chen Z; Wang G; Jing H; Zhang X; Li M; Peng J; Tian X
    Shock; 2014 Nov; 42(5):440-7. PubMed ID: 25004063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.